% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@INPROCEEDINGS{Hahn:905419,
author = {Hahn, Lisa and Eickhoff, Simon and Consortium, German FTLD
and Otto, Markus and Dukart, Jürgen and Schroeter,
Matthias},
title = {{R}esting-state alterations in behavioral variant
frontotemporal dementia are related to the distribution of
monoamine and {GABA} neurotransmitter systems},
reportid = {FZJ-2022-00660},
year = {2021},
abstract = {Introduction: Aside to changes in personality and behavior,
behavioral variant frontotemporal dementia (bvFTD) is
characterized by progressive structural and functional
alterations in frontal and temporal regions. Only little is
known about the underlying mechanisms leading to the
anatomical constraints of the pathophysiology. Here, we
evaluated if these alterations are linked to the
distribution of specific neurotransmitter systems.Methods:
Maps of fractional amplitude of low frequency fluctuations
(fALFF) were derived as a measure of local activity from
resting state functional magnetic resonance imaging for 52
bvFTD patients and 22 healthy controls (HC). We tested if
alterations in the fALFF signal of bvFTD patients
co-localize with the known non-pathological distribution of
specific neurotransmitter systems and their coding mRNA gene
expression. Furthermore, we evaluated if the strength of
this co-localization is associated with respective symptom
severity.Results: Compared to HC, patients displayed
significantly reduced fractional amplitude of low frequency
fluctuations in fronto-temporal and fronto-parietal regions.
These alterations significantly co-localized with the
distribution of serotonin (5-HT1b, 5-HT2a), dopamine (D2),
and gamma-aminobutyric acid type A receptors, the
noradrenaline transporter, and their encoding mRNA gene
expression. The strength of the co-localization with D2 and
noradrenaline transporter was associated with cognitive
symptoms of bvFTD. Conclusion: Local brain functional
activity reductions in bvFTD follow the distribution of
specific neurotransmitter systems supporting the notion of
the preferential vulnerability of specific neurotransmitter
systems. These findings provide novel insight into
neuropathophysiological mechanisms underlying functional
alterations in bvFTD.},
month = {Nov},
date = {2021-11-24},
organization = {DGPPN Kongress, Berlin (Germany), 24
Nov 2021 - 27 Nov 2021},
subtyp = {After Call},
cin = {INM-7},
cid = {I:(DE-Juel1)INM-7-20090406},
pnm = {5253 - Neuroimaging (POF4-525)},
pid = {G:(DE-HGF)POF4-5253},
typ = {PUB:(DE-HGF)6},
url = {https://juser.fz-juelich.de/record/905419},
}